Try the modernized ClinicalTrials.gov beta website. Learn more about the modernization effort.
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

A Mixed Methods Investigation of Equine-assisted Occupational Therapy for Children With Autism

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03493347
Recruitment Status : Completed
First Posted : April 10, 2018
Last Update Posted : April 12, 2019
Sponsor:
Information provided by (Responsible Party):
Wendy Wood, Colorado State University

Brief Summary:
Children with autism spectrum disorders (ASD) often participate in equine-assisted interventions, where practitioners partner with horses to improve the health and well-being of the clients they serve. One of these interventions is equine-assisted occupational therapy (EAOT). The first aim of this study is to assess the effectiveness of EAOT at improving the social, behavioral, and occupational functioning of children with ASD. Second, this study aims to conceptually develop the theory of change that guides how horses are integrated into occupational therapy for children with ASD. Eight children with ASD will participate in 10 weeks of EAOT. The quantitative strand will involve caregivers filling out measures of social functioning, self-regulation, and occupational performance on a weekly basis. Investigators hypothesize children will demonstrate improved performance on these measures during the intervention in comparison to baseline. The qualitative strand will consist of interviews with the providing occupational therapists aimed at understanding the theory behind why the intervention is effective. The results of this study will have implications for children with ASD, their families, and occupational therapists providing services to individuals with ASD.

Condition or disease Intervention/treatment Phase
Autism Spectrum Disorder Behavioral: Equine-assisted Occupational Therapy Not Applicable

Show Show detailed description

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 8 participants
Allocation: N/A
Intervention Model: Single Group Assignment
Intervention Model Description: multiple baseline single case experimental design
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: A Mixed Methods Investigation of Equine-assisted Occupational Therapy for Children With Autism
Actual Study Start Date : July 24, 2017
Actual Primary Completion Date : December 18, 2017
Actual Study Completion Date : December 31, 2018

Resource links provided by the National Library of Medicine


Arm Intervention/treatment
Experimental: Equine-assisted Occupational Therapy
All children will receive the Equine-assisted Occupational Therapy (EAOT) intervention, which includes occupational therapy administered in an equine environment. Common intervention activities include grooming, tacking, mounting, and riding the horse.
Behavioral: Equine-assisted Occupational Therapy
Occupational therapy provided in an equine environment that includes activities such as groundwork, grooming, tacking, mounting, and riding horses




Primary Outcome Measures :
  1. Change in Visual Analog Scale (VAS) ratings of individualized occupational performance goals [ Time Frame: daily, during baseline and intervention phases (up to 119 days) ]
    Parents rate their child's performance on an individualized goal using a sliding scale. The minimum score of 0, indicated on the left of the scale, denotes poor performance, while the maximum score 100, on the right of the scale, denotes excellent performance.


Secondary Outcome Measures :
  1. Change in Irritability [ Time Frame: Weekly during baseline and intervention phases, up to 18 weeks. Also during 3-month follow-up. ]
    Irritability subscale of the Aberrant Behavior Checklist- Community (ABC-C). The minimum score of 0 denotes an absence of irritable behaviors, while to maximum score of 45 denotes frequent and severe irritable behaviors.

  2. Change in Hyperactivity [ Time Frame: Weekly during baseline and intervention phases, up to 18 weeks. Also at 3-month follow up. ]
    Hyperactivity subscale of the Aberrant Behavior Checklist- Community (ABC-C). The minimum score of 0 denotes an absence of hyperactive behaviors, while the maximum score of 48 denotes frequent and severe hyperactive behaviors.

  3. Change in Social Functioning [ Time Frame: 4 Time Points: initial, after 5-7 weeks of no-treatment baseline, after 10 weeks of intervention, and after a 3-month follow-up period. ]
    Parent ratings on the Social Responsiveness Scale, Second Edition. The scale ranges from 0 - 195, where higher scores indicate more social impairment.

  4. Change in Canadian Occupational Performance Measure [ Time Frame: 4 Time Points: initial, after 5-7 weeks of no-treatment baseline, after 10 weeks of intervention, and after a 3-month follow-up period. ]
    Parent ratings of performance and satisfaction with their child's progress towards individualized goals. Administered in a semi-structured interview format. Ratings range from 0 - 10, where larger scores indicate better performance or higher levels of satisfaction.


Other Outcome Measures:
  1. Parent Perceptions of Child's Response to Treatment [ Time Frame: Two time points: 1-2 months after the intervention is complete (January-February 2018) and 5 months after intervention is complete (May 2018) ]
    Semi-structured interviews with parents to obtain their perceptions of the therapy

  2. Therapist Clinical Reasoning [ Time Frame: Weekly basis for 10 weeks throughout intervention phase. ]
    Semi-structured interviews with therapists to understand their clinical reasoning guiding how the intervention was designed and delivered



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   5 Years to 14 Years   (Child)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • aged 5-14
  • have an ASD diagnosis by a community provider
  • score ≥15 on the Social Communication Questionnaire
  • score ≥11 on the Aberrant Behavior Checklist-Community
  • meets clinical cut-offs for ASD on the Autism Diagnostic Observation Schedule, Second Edition
  • score ≥55 on the Leiter International Performance Scale, Third Edition
  • can tolerate a helmet
  • can participate in 10-minutes of riding while following safety rules
  • meets physical, mental, and emotional standards set forth by the Professional Association of Therapeutic Horsemanship, International

Exclusion Criteria:

  • behavioral issues that could interfere with safety
  • 2 hours or more of previous experience with equine-assisted interventions in the last 6 months
  • weight exceeding 200 pounds

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03493347


Locations
Layout table for location information
United States, Colorado
Hearts and Horses Therapeutic Riding Center
Loveland, Colorado, United States, 80537
Sponsors and Collaborators
Colorado State University
Investigators
Layout table for investigator information
Principal Investigator: Wendy Wood, Ph.D. Colorado State University
Publications:
Lord, C., Rutter, M., DiLavore, P., RISI, S., Gotham, K., & Bishop, S. (2012). Autism Diagnostic Observation Schedule, Second Edition. Los Angeles, CA: Western Psychological Services.
Roid, G. H., & Miller, L. J. (1997). Leiter International Performance Scale- Revised. Wood Dale, IL: Stoelting.
Rutter, M., & Bailey, A. (2003). Social Communication Questionnaire. Los Angeles, CA: Western Psychological Services.
Kazdin, A. E. (2011). Single-case research designs: Methods for clinical and applied settings . Oxford University Press.
Strauss A., & Corbin, J. (1990). Basics of Qualitative Research. Newbury Park, CA: Sage Publishing.

Layout table for additonal information
Responsible Party: Wendy Wood, Director of Research, Temple Grandin Equine Center, Colorado State University
ClinicalTrials.gov Identifier: NCT03493347    
Other Study ID Numbers: 17-7112H
First Posted: April 10, 2018    Key Record Dates
Last Update Posted: April 12, 2019
Last Verified: April 2019
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Additional relevant MeSH terms:
Layout table for MeSH terms
Autistic Disorder
Autism Spectrum Disorder
Child Development Disorders, Pervasive
Neurodevelopmental Disorders
Mental Disorders